A Las Vegas couple has filed a lawsuit against the company Pfizer for one of their birth control products, which they believe causes brain cancer.

U.S. stock markets, in all likelihood, are set to close a solid 2024 after an impressive 2023. Although most of the rally has ...

Regenxbio’s investigational gene therapy improved muscle function for patients with Duchenne muscular dystrophy (DMD) in a ...

GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced the appointment of Heidi Chen as Chief ...

Wilson celebrates the first U.S. patient to complete gene therapy for sickle cell, but says advocacy must continue.

In another sign of biopharma's waning interest in the traditional ex vivo gene therapy approach, CSL Behring is shutti | CSL ...

Though the strategic shift allows pharma to offer integrated health solutions, diversify revenue and improve patient outcomes ...

High-yield dividend stocks have been gaining momentum ahead of potential Fed rate cuts. While sticky inflation and possible ...

A U.S. stock rally fueled by Donald Trump’s election victory is stumbling, as investors contend with everything from renewed ...

Many scientists at the federal health agencies await the second Donald Trump administration with dread as well as uncertainty ...

For young, healthy people who may be wondering, “do I need a COVID booster at all?”, having one annually is sensible.

RNA vaccines saved lives during the COVID-19 pandemic, but older people had less of an immune response to the vaccines than did younger adults. Why? Boston Children's researchers, led by Byron Brook, ...